设为首页 加入收藏

TOP

LUMIGAN(bimatoprost ophthalmic solution)
2015-07-06 19:28:44 来源: 作者: 【 】 浏览:344次 评论:0

Generic Name and Formulations:
Bimatoprost 0.01%, 0.03%; oph soln; contains benzalkonium chloride.

Company:
Allergan
Indications for LUMIGAN:
Reduction of elevated intraocular pressure in open-angle glaucoma or ocular hypertension.

Adult:
≥16yrs: 1 drop once daily in the PM.

Children:
<16yrs: not recommended.

Pharmacological Class:
Prostamide analogue.

Warnings/Precautions:
Do not exceed recommended dose. Renal or hepatic impairment. Ocular inflammation. Aphakia. Pseudophakia with torn posterior lens capsule. Risk of macular edema. Contact lenses (remove; may reinsert lenses 15 minutes after administration). Pregnancy (Cat.C). Nursing mothers.

Interactions:
Allow at least 5 minutes between application of other topical ophthalmic agents.

Adverse Reactions:
Conjunctival hyperemia, eyelash growth, ocular itching or dryness, visual disturbances, foreign body sensation, other local effects, increased ocular pigmentation (iris, eyelid, eyelashes; may be permanent), other eyelash changes, blepharitis, cataract, keratitis, photophobia, infection, headache, abnormal liver function tests, asthenia, hirsutism.

How Supplied:
Soln—2.5mL, 5mL, 7.5mL 

以下是“全球医药”详细资料
Tags: 责任编辑:admin
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇Synagis (palivizumab) 下一篇LUMIGAN (bimatoprost ophthalmic..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位